Insulin Delivery Device Market worth $26.37 billion by 2031
The report "Insulin Delivery Devices Market by Type [Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others], Application [Type 1 Diabetes, Type 2 Diabetes] - Global Forecast to 2031" is projected to reach USD 26.37 billion in 2031 from USD 16.92 billion in 2026, at a CAGR of 9.3% during the forecast period.
Browse 300 market data Tables and 60 Figures spread through 350 Pages and in-depth TOC on "Insulin Delivery Devices Market, By Type [Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others], Application [Type 1 Diabetes, Type 2 Diabetes] - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/insulin-delivery-device-market-107632092.html
The insulin delivery devices market is driven by the rising prevalence of diabetes, advances in insulin administration technology, and growing healthcare spending on diabetes management. Growing adoption of insulin pens, insulin pumps, and automated insulin delivery systems is improving dosing convenience, accuracy, and treatment adherence. Favorable reimbursement policies and government initiatives to improve diabetes care further support market expansion. Additionally, rising R&D investment, strategic collaborations, and innovations in smart insulin pens, tubeless pumps, and safety-engineered needles are creating growth opportunities. Expanding healthcare infrastructure, rising patient awareness, and increasing demand for convenient, personalized diabetes management solutions are expected to further accelerate market adoption worldwide.
By type of insulin pens, the reusable insulin pens segment held the major share in 2025.
The insulin delivery devices market is segmented based on type into insulin pens, insulin pumps, insulin pen needles, insulin syringes, and other insulin delivery devices. The insulin pens segment is further divided into reusable and disposable insulin pens. In 2025, reusable insulin pens held the largest share of the global insulin delivery devices market by type, supported by their cost-effectiveness, convenience, and suitability for long-term diabetes management. These devices let patients replace insulin cartridges while keeping the pen mechanism, reducing the need to buy an entirely new pen after each cartridge is exhausted. Their durable design, accurate dosing, portability, and ease of use support adoption among patients who require regular insulin injections. Additionally, compatibility with different insulin cartridges and disposable pen needles makes reusable pens a practical option for routine diabetes care, particularly for cost-conscious users.
By application, the type 2 diabetes segment accounted for the largest share of the market in 2025.
Based on application, the insulin delivery devices market is segmented into type 2 diabetes and type 1 diabetes. The type 2 diabetes segment held the largest share of the global insulin delivery devices market in 2025, primarily because type 2 diabetes is far more prevalent worldwide. According to the International Diabetes Federation (IDF), over 90% of people with diabetes have type 2 diabetes, driven by socioeconomic, demographic, environmental, and genetic factors. Although many patients initially manage the condition through lifestyle modifications and non-insulin medications, disease progression can increase the need for insulin therapy. Consequently, demand for insulin pens, syringes, pen needles, and insulin pumps among eligible patients supports segment growth. The growing population requiring long-term diabetes management further drives demand for insulin delivery devices.
In 2025, Asia Pacific accounted for the second-largest share of the market.
Asia Pacific held the second-largest share of the global insulin delivery devices market in 2025, supported by its substantial diabetes population and increasing demand for effective diabetes management. According to the International Diabetes Federation (IDF), China recorded approximately 148.0 million adults with diabetes in 2024, while India reported 89.8 million and Japan approximately 9.0 million. The high disease burden across these countries creates considerable demand for insulin pens, pen needles, syringes, and insulin pumps. Additionally, population aging, urbanization, changing dietary patterns, and sedentary lifestyles contribute to the growing burden of type 2 diabetes. Expanding healthcare infrastructure, improving diabetes awareness, and increasing access to medical devices are also supporting regional adoption.
Key Players
Some of the prominent players operating in the market include Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed (Switzerland), Medtronic (Ireland), Tandem Diabetes Care, Inc. (US), Sanofi (France), Eli Lilly and Company (US), Insulet Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), Terumo Corporation (Japan), and others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Insulin Delivery Devices Market
- What will your New Revenue Sources be
- Who will be your Top Customer; what will make them switch
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
